(Q27852071)
Statements
1 reference
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer (English)
1 reference
20 March 2013
0 references
31
0 references
9
0 references
1157-63
0 references